{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:35:10Z","timestamp":1761100510512},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7068,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1023\/a:1008395400069","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"1141-1146","source":"Crossref","is-referenced-by-count":12,"title":["Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255"],"prefix":"10.1016","volume":"11","author":[{"given":"S.M.","family":"Lichtman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Niedzwiecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.L.","family":"Barcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carlisle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008395400069_bb0005","first-page":"503","article-title":"The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma","volume":"25","author":"Laport","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008395400069_bb0010","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008395400069_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1200\/JCO.1988.6.3.425","article-title":"COPBLAM III: Incisional combination chemotherapy for diffuse large-cell lymphoma","volume":"6","author":"Boyd","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00000421-199502000-00009","article-title":"Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma","volume":"18","author":"Carrion","year":"1995","journal-title":"Am J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/07357909709047586","article-title":"Infusional chemotherapy for non-Hodgkin's lymphoma","volume":"15","author":"Molldrem","year":"1997","journal-title":"Cancer Invest"},{"key":"10.1023\/A:1008395400069_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00000421-199702000-00021","article-title":"CODBLAM IV chemotherapy for large cell lymphoma: Sequential use of infusional vincristine and bleomycin and 'high-dose' consolidation","volume":"20","author":"Ran","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1993.11.6.1071","article-title":"Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: Evidence for a schedule-dependent effect favoring infusional administration of chemotherapy","volume":"11","author":"Sparano","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0040","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1200\/JCO.1993.11.7.1322","article-title":"Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: A phase I-II study","volume":"11","author":"Thompson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0045","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/07357909309018868","article-title":"COP-BLAM multidrug infusion chemotherapies for lymphoma: Results in a community hospital setting","volume":"11","author":"Topilow","year":"1993","journal-title":"Cancer Invest"},{"key":"10.1023\/A:1008395400069_bb0050","doi-asserted-by":"crossref","first-page":"190","DOI":"10.7326\/0003-4819-97-2-190","article-title":"Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen","volume":"97","author":"Laurence","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1008395400069_bb0055","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1200\/JCO.1993.11.8.1573","article-title":"EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma","volume":"11","author":"Wilson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0060","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008395400069_bb0065","first-page":"384a","article-title":"Dose-intensified cyclophosphamide (C) and etoposide (E) in CHOP plus E (CHOPE) therapy of diffuse lymphomas (IWF E-H), CALGB 8852 (Meeting abstract)","volume":"84","author":"Parker","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008395400069_bb0070","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1023\/A:1008395400069_bb0075","first-page":"2005a","article-title":"High-dose CHOP induction therapy for poor prognosis aggressive NHL (CALGB 9351): FFP differs at high and low accrual institutions","volume":"92","author":"Shipp","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008395400069_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1023\/A:1008395400069_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez","year":"1988","journal-title":"Blood"},{"key":"10.1023\/A:1008395400069_bb0090","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","article-title":"ESHAP-an effective chemotherapy regimen in refractory and relapsing lymphoma: A four-year follow-up study","volume":"12","author":"Velasquez","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008395400069_bb0095","first-page":"58","article-title":"Ifosfamide combinations in lymphoma","volume":"17","author":"Cabamllas","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008395400069_bb0100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008395400069_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00685734","article-title":"A phase I trial of high-dose oral tamoxifen and CHOPE","volume":"36","author":"Smith","year":"1995","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420311996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420311996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/9\/1141\/19478500\/11-9-1141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:37:02Z","timestamp":1582166222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420311996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0923753420311996"],"URL":"https:\/\/doi.org\/10.1023\/a:1008395400069","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}